Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New substances in oncologic therapy].

F Cavalli

    Schweizerische Medizinische Wochenschrift
    |August 12, 1978
    PubMed
    Summary
    This summary is machine-generated.

    This study reviews new cytostatic agents, highlighting adriamycin, diaminodichloro-cisplatinum, and VP 16-213 as breakthroughs in cancer therapy. It also discusses methodological challenges and emerging drugs in early development.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Publisher Correction: Clinical characteristics of vulnerable populations hospitalized and diagnosed with COVID-19 in Buenos Aires, Argentina.

    Scientific reports·2021
    Same author

    Clinical characteristics of vulnerable populations hospitalized and diagnosed with COVID-19 in Buenos Aires, Argentina.

    Scientific reports·2021
    Same author

    Agents' beliefs and economic regimes polarization in interacting markets.

    Chaos (Woodbury, N.Y.)·2018
    Same author

    Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Real and financial market interactions in a multiplier-accelerator model: Nonlinear dynamics, multistability and stylized facts.

    Chaos (Woodbury, N.Y.)·2017
    Same author

    [RECONSTRUCTING THE LIFE OF AN UNKNOWN MAN--INTERDISCIPLINARY APPROACH].

    Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
    Same journal

    Respiratory function test in the case of temporary phrenic nerve contusion, associated with pneumoperitoneum; About the diagnostic value of laparoscopy.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Treatment of pulmonary tuberculosis and pleurisy by means of temporary paralysis of the diaphragm, supported by the pneumoperitoneum.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Boeck's disease as a tuberculous syndrome.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Enteral primary tubercular complexes

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    Tuberculous stenoses of the large bronchi.

    Schweizerische medizinische Wochenschrift·2010
    Same journal

    About the enzyme action.

    Schweizerische medizinische Wochenschrift·2010
    See all related articles

    Area of Science:

    • Oncology
    • Pharmacology
    • Drug Development

    Context:

    • Challenges in developing novel cytostatic agents.
    • Review of recent advancements in cancer therapeutics.

    Purpose:

    • To discuss methodological problems in developing new cytostatic agents.
    • To review the pharmacology and activity spectra of newer substances.
    • To identify breakthroughs in therapeutic oncology.

    Summary:

    • Adriamycin, diaminodichloro-cisplatinum, and VP 16-213 represent significant advancements in cancer treatment.
    • The study examines nitroso-urea derivatives, ICDT, and tamoxifen.
    • Emerging drugs currently in Phase I clinical trials are also mentioned.

    Impact:

    • Identifies key breakthroughs in cancer drug development.
    • Provides a concise overview of promising new cytostatic agents.
    • Highlights areas for future research in therapeutic oncology.